Tokyo, Oct. 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059548) titled 'The Prevalence of Probable Generalized Anxiety Disorder in General Internal Medicine Clinics: A multicenter, cross-sectional study in Japan' on Oct. 31.
Study Type:
Observational
Primary Sponsor:
Institute - Viatris Pharmaceuticals Japan G.K.
Condition:
Condition - Generalized Anxiety Disorder
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the extent to which patients with probable GAD are present in general internal medicine clinics, excluding psychiatry and psychosomatic medicine.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-ol...